Home
NGHIÊN CỨU LÂM SÀNG
Issue: Số 91+92, 2021
Article
Phan Tuấn Đạt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Phạm Mạnh Hùng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Lân Việt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Published: August 1, 2020
Views: 147
References
1.
1. ThomasJCahill,RajeshKKharbanda(2017). Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. WorldJCardiol; 9(5): 407-415.
2.
2. Delewi R, Hirsch A, Tijssen JG, et al (2014). Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J; 35(15), 989-98.
3.
3. Staat,P,etal(2005). Postconditioning the human heart. Circulation; 112(14): 2143-8.
4.
ShoneO.Almeida,RhysJ.Skelton,etal(2015). Arrhythmia in Stem Cell Transplantation. Card ElectrophysiolClin; 7(2): 357-370.
5.
4. Menasché P, Alfieri O, et al (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation; 117: 1189-1200.
6.
5. Mills WR, Mal N, Kiedrowski MJ, et al (2007). Stem cell therapy enhances electrical via- bility in myocardial infarction. JMolCellCardiol; 42: 304-14.
7.
6. Schachinger V, et al (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. EurHeartJ; (27), 2775-83.
8.
7. Janssens S, Dubois C, et al (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet; 367:113-121.
9.
8. Lunde K, Solheim S, et al (2008). Anterior myocardial infarction with acute percutaneous coronary inter- vention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months’ follow-up. J Am Coll Cardiol; 51:674-676.
10.
9. Wollert KC, Meyer GP, et al (2004). Intracoronary autologous bone- marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet; 364:141-148.